Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand

Journal of Medicinal Chemistry

Volumn 39, Issue 22, 1996, Pages 4515-4519

  Khanolkar, Atmaram D ^a   Abadji, Vasiliki ^a   Lin, Sonyuan ^a   Hill, W Adam G ^a   Taha, Gihan ^a   Abouzid, Khaled ^a   Meng, Zhaoxing ^a   Fan, Pusheng ^a   Makriyannis, Alexandros ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SYNTHESIS; MOUSE; NONHUMAN; RECEPTOR AFFINITY; SPLEEN;

ADJUVANTS, IMMUNOLOGIC; ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; BRAIN; CALCIUM CHANNEL BLOCKERS; CYCLOHEXANOLS; KINETICS; MICE; POLYUNSATURATED ALKAMIDES; RATS; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029960523     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960152y     Document Type: Article

References (31)

1. Devane, W. A.; Hanus, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor. Science 1992, 258, 1946-1949.
2. Felder, C. C.; Briley, E. M.; Axelrod, J.; Simpson, J. T.; Mackie, K.; Devane, W. A. Anandamide, an Endogenous Cannabimimetic Eicosanoid, Binds to the Cloned Human Cannabinoid Receptor and Stimulates Receptor-Mediated Signal Transduction. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 7656-7660.
3. Mackie, K.; Devane, W. A.; Hille, B. Anandamide, an Endogenous Cannabinoid, Inhibits Calcium Currents as a Partial Agonist in N18 Neuroblastoma Cells. Mol. Pharmacol. 1993, 44, 498-503.
4. Vogel, Z.; Barg, J.; Levy, R.; Saya, D.; Heldman, E.; Mechoulam, R. Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate Cyclase. J. Neurochem. 1993, 61, 352-355.
5. Pertwee, R. G.; Stevenson, L. A.; Elrick, D. B.; Mechoulam, R.; Corbett, A. D. Inhibitory Effects of Certain Enantiomeric Cannabinoids in the Mouse Vas Deferens and the Myenteric Plexus Preparation of Guinea-pig Small Intestine. Br. J. Pharmacol. 1992, 105, 980-984.
6. Pertwee, R. G.; Fernando, S. R.; Griffin, G.; Abadji, V.; Makriyannis, A. Effect of Phenylmethylsulfonyl Fluoride on the Potency of Anandamide as an Inhibitor of Electrically Evoked Contractions in Two Isolated Tissue Preparations. Eur. J. Pharmacol. 1995, 272, 73-78.
7. Smith, P. B.; Compton, D. R.; Welch, S. P.; Razdan, R. K.; Mechoulam, R.; Martin, B.R. The Pharmacological Activity of Anandamide, a Putative Endogenous Cannabinoid, in Mice. J. Pharmcol. Exp. Ther. 1994, 270, 219-227.
8. Varga, K.; Lake, K.; Martin, B. R.; Kunos, G. Novel Antagonist Implicates the CB1 Cannabinoid Receptor in the Hypotensive Action of Anandamide. Eur. J. Pharmacol. 1995, 278, 279-283.
9. 9-THC-Induced Antinociception. J. Pharmcol. Exp. Ther. 1995, 273, 1235-1244.
10. Pertwee, R. G.; Stevenson, L. A.; Griffin, G. Cross-tolerance between Delta-9-tetrahydrocannabinol and the Cannabimimetic Agents CP 55,940, WIN 55,212-2 and Anandamide. Br. J. Pharmacol. 1993, 110, 1483-1490.
11. Pertwee, R. G.; Stevenson, L. A. Effect of Pretreatment with Delta-9-tetrahydro-cannabinol on the Ability of Certain Cannabimimetic Agents to Induce Hypothermia in Mice. In Temperature Regulation. Recent Physiological and Pharmacological Advances; Milton, A. S., Ed.; Birkhäuser: Basel, 1994; pp 177-182.
12. Deutsch, D. G.; Chin, S. A. Enzymatic Synthesis and Degradation of Anandamide, a Cannabinoid Receptor Agonist. Biochem. Pharmacol. 1993, 46, 791-796.
13. Kutek, B.; Prestwich, G. D.; Hewlett, A. C.; Chin, S. A.; Salehani, D.; Akhavan, N.; Deutsch, D. G. Inhibitors of Arachidonoyl Ethanolamide Hydrolysis. J. Biol. Chem. 1994, 269, 22937-22940.
14. Deutsch, D.; Makriyannis, A. Anandamide Amidase Inhibitors. NIDA Res. Monograph, in press.
15. Abadji, V.; Lin, S.; Taha, G.; Griffin, G.; Stevenson, L. A.; Pertwee, R. G.; Makriyannis, A. (R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability. J. Med. Chem. 1994, 37, 1889-1893.
16. Pinto, J. C.; Potie, F.; Rice, K. C.; Boring, D.; Johnson, M. R.; Evans, D. M.; Wilken, G. H.; Cantrell, C. H.; Howlett, A. C. Cannabinoid Receptor Binding and Agonist Activity of Amides and Esters of Arachidonic Acid. Mol. Pharmacol. 1994, 46, 516-522.
17. Adams, I. B.; Ryan, W.; Singer, M.; Razdan, R. K.; Compton, D. R.; Martin, B. R. Pharmacological and Behavioral Evaluation of Alkylated Anandamide Analogs. Life Sci. 1995, 56, 2041-2048.
18. Adams, I. B.; Ryan, W.; Singer, M.; Thomas, B. F.; Compton, D. R.; Razdan, R. K.; Martin, B. R. Evaluation of Cannabinoid Receptor Binding and In Vivo Activities for Anandamide Analogs. J. Pharmcol. Exp. Ther. 1995, 273, 1172-1181.
19. Kaminski, N. E.; Abood, M. E.; Kessler, F. K.; Martin, B. R.; Schatz, A. R. Identification of a Functionally Relevant Cannabinoid Receptor on Mouse Spleen Cells that is Involved in Cannabinoid-mediated Immune Modulation. Mol. Pharmacol. 1992, 42, 736-742.
20. Munro, S.; Thomas, K. L.; Abu, S. M. Molecular Characterization of a Peripheral Receptor for Cannabinoids. Nature 1993, 365, 61-65.
21. Felder, C. C.; Joyce, K. E.; Briley, E. M.; Mansouri, J.; Mackie, K.; Blond, O.; Lai, Y.; Ma, A. L.; Mitchell, R. L. Comparison of the Pharmacology and Signal Transduction of the Human Cannabinoid CB1 and CB2 Receptors. Mol. Pharmacol. 1995, 48, 443-450.
22. Raucher, S.; Klein, P. A Convenient Method for the Selective Reduction of Amides to Amines. Tetrahedron. Lett. 1980, 21, 4061-44.
23. Hill, W. A. G.; Morse, K. L.; Colasanto, J.; Khanolkar, A. D.; Makriyannis, A. Structure Activity Relationships Between Classical Cannabinoids on the Central (CB1) and the Peripheral (CB2) Cannabinoid Receptors. Unpublished results.
24. Devane, W. A.; Dysarz, F. A., III; Johnson, R. M.; Melvin, L. S.; Howlett, A. C. Determination and Characterization of a Cannabinoid Receptor in Rat Brain. Mol. Pharmacol. 1988, 34, 605-613.
25. 8-THC: A Novel Photoaffinity Label for the Cannabinoid Receptor. J. Med. Chem. 1992, 35, 3076-3079.
26. 50) of an Enzymatic Reaction. Biochem. Pharmacol. 1973, 22, 3099-3102.
27. Razdan, R. K. Structure-Activity Relationships in Cannabinoids. Pharmacol. Rev. 1986, 38, 75-149.
28. Makriyannis, A.; Rapaka, R. S. The Molecular Basis of Cannabinoid Activity. Life Sci. 1990, 47, 2173-2184.
29. Gareau, Y.; Dufresne, C.; Gallant, M.; Rochette, C.; Sawyer, N.; Slipetz, D. M.; Tremblay, N.; Weech, P. K.; Metters, K. M.; Labelle, M. Structure Activity Relationships of Tetrahydrocannabinol Analogues on Human Cannabinoid Receptors. Bioorg. Med. Chem. Lett. 1996, 6, 189-194.
30. Edgemond, W. S.; Campbell, W. B.; Hillard, C. J. The Binding of Novel Phenolic Derivatives of Anandamide to Brain Cannabinoid Receptors. Prostaglandins, Leukotrienes Essent. Fatty Acids 1995, 52, 83-86.
31. Dodd, P. R.; Hardy, J. A.; Oakley, A. E.; Edwardson, J. A.; Perry, E. K; Delaunoy, J.-P. A Rapid Method for Preparing Synaptosomes: Comparison with Alternative Procedures. Brain Res. 1981, 226, 107-118.